BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22326301)

  • 1. Clinical Escherichia coli isolates utilize alpha-hemolysin to inhibit in vitro epithelial cytokine production.
    Hilbert DW; Paulish-Miller TE; Tan CK; Carey AJ; Ulett GC; Mordechai E; Adelson ME; Gygax SE; Trama JP
    Microbes Infect; 2012 Jul; 14(7-8):628-38. PubMed ID: 22326301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection.
    Nagamatsu K; Hannan TJ; Guest RL; Kostakioti M; Hadjifrangiskou M; Binkley J; Dodson K; Raivio TL; Hultgren SJ
    Proc Natl Acad Sci U S A; 2015 Feb; 112(8):E871-80. PubMed ID: 25675528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in hemolysin A expression between uropathogenic
    Murthy AMV; Sullivan MJ; Nhu NTK; Lo AW; Phan MD; Peters KM; Boucher D; Schroder K; Beatson SA; Ulett GC; Schembri MA; Sweet MJ
    FASEB J; 2019 Jun; 33(6):7437-7450. PubMed ID: 30869997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemolysin of uropathogenic Escherichia coli: A cloak or a dagger?
    Ristow LC; Welch RA
    Biochim Biophys Acta; 2016 Mar; 1858(3):538-45. PubMed ID: 26299820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bis-molybdopterin guanine dinucleotide modulates hemolysin expression under anaerobiosis and contributes to fitness in vivo in uropathogenic Escherichia coli.
    Zhang X; Huang D; Zhao Z; Cai X; Cai W; Li G
    Mol Microbiol; 2021 Oct; 116(4):1216-1231. PubMed ID: 34494331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Haemolysin production, as a single factor, causes fulminant sepsis in a model of Escherichia coli-induced bacteraemia.
    Johnsen N; Hamilton ADM; Greve AS; Christensen MG; Therkildsen JR; Wehmöller J; Skals M; Praetorius HA
    Cell Microbiol; 2019 Jun; 21(6):e13017. PubMed ID: 30761726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of hemolysin in uropathogenic Escherichia coli fine-tunes killing of human macrophages.
    M V Murthy A; Phan MD; Peters KM; Nhu NTK; Welch RA; Ulett GC; Schembri MA; Sweet MJ
    Virulence; 2018 Dec; 9(1):967-980. PubMed ID: 29683762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MOLECULAR CHARACTERIZATION OF VIRULENCE AND ANTIMICROBIAL SUSCEPTIBILITY PROFILES OF UROPATHOGENIC ESCHERICHIA COLI FROM PATIENTS IN A TERTIARY HOSPITAL, SOUTHERN THAILAND.
    Themphachanal M; Kongpheng S; Rattanachuay P; Khianngam S; Singkhamanan K; Sukhumungoon P
    Southeast Asian J Trop Med Public Health; 2015 Nov; 46(6):1021-30. PubMed ID: 26867360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A previously uncharacterized two-component signaling system in uropathogenic Escherichia coli coordinates protection against host-derived oxidative stress with activation of hemolysin-mediated host cell pyroptosis.
    Gu H; Cai X; Zhang X; Luo J; Zhang X; Hu X; Cai W; Li G
    PLoS Pathog; 2021 Oct; 17(10):e1010005. PubMed ID: 34653218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BarA-UvrY two-component system regulates virulence of uropathogenic E. coli CFT073.
    Palaniyandi S; Mitra A; Herren CD; Lockatell CV; Johnson DE; Zhu X; Mukhopadhyay S
    PLoS One; 2012; 7(2):e31348. PubMed ID: 22363626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation of mice.
    Smith YC; Rasmussen SB; Grande KK; Conran RM; O'Brien AD
    Infect Immun; 2008 Jul; 76(7):2978-90. PubMed ID: 18443089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ppGpp, the General Stress Response Alarmone, Is Required for the Expression of the α-Hemolysin Toxin in the Uropathogenic
    Fernández-Vázquez J; Cabrer-Panes JD; Åberg A; Juárez A; Madrid C; Gaviria-Cantin T; Fernández-Coll L; Vargas-Sinisterra AF; Jiménez CJ; Balsalobre C
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uropathogenic Escherichia coli Virulence Factor α-Hemolysin Reduces Histone Acetylation to Inhibit Expression of Proinflammatory Cytokine Genes.
    Zhang Z; Wang M; Zhang Y; Zhang Y; Bartkuhn M; Markmann M; Hossain H; Chakraborty T; Hake SB; Jia Z; Meinhardt A; Bhushan S
    J Infect Dis; 2021 Mar; 223(6):1040-1051. PubMed ID: 33453118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against hemolysin and cytotoxic necrotizing factor type 1 (CNF1) reduce bladder inflammation in a mouse model of urinary tract infection with toxigenic uropathogenic Escherichia coli.
    Smith MA; Weingarten RA; Russo LM; Ventura CL; O'Brien AD
    Infect Immun; 2015 Apr; 83(4):1661-73. PubMed ID: 25667267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common origin of plasmid encoded alpha-hemolysin genes in Escherichia coli.
    Burgos Y; Beutin L
    BMC Microbiol; 2010 Jul; 10():193. PubMed ID: 20637130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both alpha-haemolysin determinants contribute to full virulence of uropathogenic Escherichia coli strain 536.
    Nagy G; Altenhoefer A; Knapp O; Maier E; Dobrindt U; Blum-Oehler G; Benz R; Emody L; Hacker J
    Microbes Infect; 2006 Jul; 8(8):2006-12. PubMed ID: 16787757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex Multilevel Control of Hemolysin Production by Uropathogenic Escherichia coli.
    Nhu NTK; Phan MD; Forde BM; Murthy AMV; Peters KM; Day CJ; Poole J; Kidd TJ; Welch RA; Jennings MP; Ulett GC; Sweet MJ; Beatson SA; Schembri MA
    mBio; 2019 Oct; 10(5):. PubMed ID: 31575773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The repeat-in-toxin family member TosA mediates adherence of uropathogenic Escherichia coli and survival during bacteremia.
    Vigil PD; Wiles TJ; Engstrom MD; Prasov L; Mulvey MA; Mobley HL
    Infect Immun; 2012 Feb; 80(2):493-505. PubMed ID: 22083710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.
    Bokil NJ; Totsika M; Carey AJ; Stacey KJ; Hancock V; Saunders BM; Ravasi T; Ulett GC; Schembri MA; Sweet MJ
    Immunobiology; 2011 Nov; 216(11):1164-71. PubMed ID: 21802164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection.
    Ulett GC; Totsika M; Schaale K; Carey AJ; Sweet MJ; Schembri MA
    Curr Opin Microbiol; 2013 Feb; 16(1):100-7. PubMed ID: 23403118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.